{
  "ticker": "AFP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965836",
  "id": "02965836",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250704",
  "time": "0730",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg3d4pnlp9vn.pdf",
  "summary": "- **Director Share Purchase**: Hartley Campbell Atkinson (Director of AFT Pharmaceuticals) acquired 200,000 ordinary shares at an average price of NZD $2.83 per share (~NZD $566,000 total).  \n- **Post-Transaction Holdings**: Total holding via the Atkinson Family Trust increased to **72,259,496 shares** (from 72,059,496). Direct beneficial ownership: **867,826 shares**.  \n- **Transaction Dates**: On-market purchases executed on **30 Jun, 1 Jul, and 2 Jul 2025**.  \n\n*No material impact on capital structure or liquidity identified. Disclosure reflects routine director trading.*",
  "usage": {
    "prompt_tokens": 1408,
    "completion_tokens": 136,
    "total_tokens": 1544,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T22:15:17.197946"
}